Sumitomo Dainippon Pharma Co's market cap is currently $632.89B. The company's EPS TTM is ¥28.21; its P/E ratio is 33.48; Sumitomo Dainippon Pharma Co is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is ¥77.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in JPY
Sumitomo Dainippon Pharma Co Earnings and Revenue History
